The Economic Times

GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy generics

Indian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and Torrent Pharma are identified as potential market leaders. Despite initial stockouts online, companies are adjusting supply. The market for these diabetes and obesity drugs is expected to grow significantly in India.